Systematic Reviews
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jan 21, 2016; 22(3): 1321-1330
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1321
Cytomegalovirus in inflammatory bowel disease: A systematic review
Tessa EH Römkens, Geert J Bulte, Loes HC Nissen, Joost PH Drenth
Tessa EH Römkens, Loes HC Nissen, Joost PH Drenth, Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, The Netherlands
Tessa EH Römkens, Geert J Bulte, Loes HC Nissen, Department of Gastroenterology and Hepatology, Jeroen Bosch Hospital, 5200 ME Hertogenbosch, The Netherlands
Author contributions: Römkens TEH and Bulte GJ contributed equally to this work; Römkens TEH, Bulte GJ and Drenth JPH designed the research; Römkens TEH, Bulte GJ and Nissen LHC performed the research; Römkens TEH and Bulte GJ analyzed the data and wrote the paper; Nissen LHC and Drenth JPH made critical revisions of the manuscript.
Conflict-of-interest statement: All the authors declare that they have no competing interests.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Tessa EH Römkens, MD, Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. tessa.romkens@radboudumc.nl
Telephone: +31-24-3614760 Fax: +31-24-3540103
Received: April 28, 2015
Peer-review started: May 5, 2015
First decision: August 26, 2015
Revised: October 12, 2015
Accepted: November 30, 2015
Article in press: November 30, 2015
Published online: January 21, 2016
Core Tip

Core tip: The use of different definitions for cytomegalovirus (CMV) infection and CMV intestinal disease in inflammatory bowel disease (IBD) patients has great impact on the reported prevalence rates (definitions with highest prevalence: positive serum PCR (CMV infection) and tissue PCR > 10 copies/mg tissue (CMV intestinal disease)). In addition, prevalence rates depend on the studied population (highest prevalence: steroid refractory disease), and region (highest prevalence: East Asia). Our key message is not to develop more sensitive diagnostics to find CMV, but to organise a global consensus meeting on CMV in IBD to formulate one unified definition for clinically relevant CMV (intestinal) disease in IBD.